AbbVie

As Legalization Looms, AbbVie And Other Major Pharma Players Set Sights On Cannabis Market

Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More

First Psychedelics ETF Debuts On NEO Exchange

Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More

First Psychedelics ETF Debuts On NEO Exchange

Pharma Large And Mid-Caps Race Against COVID-19

project44 Adds Air, Ocean Freight Visibility To Platform

Pharma Large And Mid-Caps Race Against COVID-19

project44 Adds Air, Ocean Freight Visibility To Platform

Barron's Picks And Pans: AbbVie, Alibaba, Fiat Chrysler, Garmin And More

Notable Insider Buys: AbbVie, Bristol-Myers And More

AbbVie Recent News

Barron's Picks And Pans: AbbVie, Crocs, RealReal, Roku And More

Barron's Picks And Pans: Conagra, JPMorgan, L Brands, Weight Watchers And More

Bulls & Bears Of The Week: AT&T, Facebook, GE, Microsoft And More

Barron's Picks And Pans: AT&T, Starbucks, State Street, Verizon And More

Benzinga's Bulls & Bears Of The Week: AbbVie, Netflix, Philip Morris, Wells Fargo And More

Benzinga's Insider Buys Of The Week: AbbVie, Energen, NuStar And More

Benzinga's Bulls & Bears Of The Week: AbbVie, Lululemon, Netflix, Snap And More

Barron's Picks And Pans: Berkshire Hathaway, Microsoft, Time Warner And More

Benzinga's Weekly Bulls & Bears: AbbVie, Kinder Morgan, Paypal, Starbucks, Wynn And More

Barron's Roundtable: A Big Basket Of Bargains For 2018

Morgan Stanley Expects Galapagos Shares To Rise 10%

Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences

Big Biotech In The Earnings Spotlight

Facebook And Amazon: More Earnings From The FANG Stocks

Chrysler And Ford Earnings: Following In GM's Footsteps?

AbbVie's Venclexta Receives Accelerated Approval From FDA, Stock Ticks Higher

AbbVie Falling After Q4 Report, 2016 Guidance Affirmation

Barron's 2016 Roundtable Part 2: Lots Of Savvy Investment Ideas

LifeSci Capital's Andrew McDonald On How To Invest In Booming Biotech

Barron's Recap: This Man Made, Lost And Made A Fortune Investing In Russia

Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Record Highs

#PreMarket Primer: Tuesday, October 21: China's Third Quarter Growth Disappoints

Markets Rebound After Getting Crushed Intraday, Still Close Lower